<div id="readability-page-1"><p>Marathon Capital Management acquired a new position in shares of  GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 12,054 shares of the company's stock, valued at approximately $893,000.</p><ul><li>GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine</li></ul><p>A number of other hedge funds and other institutional investors also recently bought and sold shares of GEHC. Vanguard Group Inc. increased its position in shares of  GE HealthCare Technologies by 1.4% during the second quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company's stock worth $3,859,622,000 after purchasing an additional 703,903 shares in the last quarter.  Dodge &amp; Cox increased its position in  GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge &amp; Cox now owns 23,567,950 shares of the company's stock valued at $1,745,678,000 after buying an additional 6,982,441 shares in the last quarter.  State Street Corp boosted its holdings in  GE HealthCare Technologies by 1.9% in the second quarter. State Street Corp now owns 19,660,742 shares of the company's stock worth $1,456,271,000 after acquiring an additional 372,755 shares in the last quarter.  Geode Capital Management LLC grew its stake in shares of  GE HealthCare Technologies by 2.0% during the second quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company's stock worth $881,060,000 after acquiring an additional 231,302 shares during the last quarter.  Finally, Norges Bank acquired a new position in shares of  GE HealthCare Technologies during the second quarter valued at about $468,120,000. Hedge funds and other institutional investors own  82.06% of the company's stock. </p><h2>GE HealthCare Technologies Stock Up 1.7%</h2><p>GEHC opened at $84.47 on Thursday. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. The stock has a market capitalization of $38.48 billion, a price-to-earnings ratio of 17.45, a PEG ratio of 3.47 and a beta of 1.10. The company has a fifty day moving average of $76.49 and a two-hundred day moving average of $74.79. </p><ul><li>Honeywell’s Breakup: Is HON Stock a Sweet Deal for Investors?</li></ul><p>GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company had revenue of $5.14 billion during the quarter, compared to analysts' expectations of $5.07 billion. During the same quarter in the prior year, the firm posted $1.14 EPS. GE HealthCare Technologies's quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS.  On average, research analysts expect that  GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year. </p><h2>GE HealthCare Technologies Announces Dividend</h2><p>The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies's dividend payout ratio  is currently 2.89%. </p><h2>Wall Street Analysts Forecast Growth</h2><ul><li>Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play</li></ul><p>GEHC has been the subject of a number of recent analyst reports. Wall Street Zen cut shares of GE HealthCare Technologies from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, September 20th. Stifel Nicolaus  set a $90.00 price target on GE HealthCare Technologies in a research note on Friday, November 21st. Zacks Research lowered GE HealthCare Technologies from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Monday, September 29th. Barclays initiated coverage on shares of GE HealthCare Technologies in a research note on Monday, October 13th. They set an &#34;equal weight&#34; rating and a $86.00 price objective for the company. Finally, Morgan Stanley raised their target price on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an &#34;equal weight&#34; rating in a report on Thursday, October 30th. Six analysts have rated the stock with a Buy rating and six have issued  a Hold rating to the company's stock. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $86.45.</p><p><b>Get Our Latest Report on GE HealthCare Technologies</b></p><h2>GE HealthCare Technologies Company Profile</h2> (Free Report)<p>GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.</p><h2>Read More</h2><ul><li>Five stocks we like better than GE HealthCare Technologies</li><li>What is the S&amp;P/TSX Index?</li><li>GameStop Looks Broken: Here’s Why GME Could Crash in 2026</li><li>The Role Economic Reports Play in a Successful Investment Strategy</li><li>Market Momentum: 3 Stocks Poised for Major Breakouts</li><li>3 Monster Growth Stocks to Buy Now</li><li>3 Reasons Casey’s General Stores Will Continue Trending Higher</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in GE HealthCare Technologies Right Now?</h2><p>Before you consider GE HealthCare Technologies, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.</p><p>While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

GEHC

<p>Marathon Capital Management acquired 12,054 shares of GE HealthCare Technologies, valued at $893,000. Other institutional investors also increased their positions. GEHC's stock opened at $84.47, with a market cap of $38.48 billion. Analysts have mixed ratings, with some downgrading to 'hold' and others setting price targets between $80-$90. GEHC reported quarterly earnings of $1.07 per share, beating estimates, and announced a dividend of $0.035 per share.</p>

Marathon Capital Management Takes Position in GE HealthCare Technologies Inc. $GEHC